Deutsche Bank analyst Omotayo Okusanya downgraded National Health Investors (NHI) to Hold from Buy with an $85 price target
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- National Health Investors price target lowered to $85 from $87 at Cantor Fitzgerald
- National Health Investors Updates Executive Change-in-Control Agreements
- National Health Investors announces $89.2M in investments
- National Health Investors price target raised to $83 from $81 at Truist
- National Health Investors price target raised to $88 from $80 at KeyBanc